Globus Medical (GMED) Shares are Down -2.4%

On a relative basis, the stock has outperformed the S&P 500 by 1.21% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week. The 4-week change in the price of the stock is -0.84% and the stock has fallen -2.4% in the past 1 week.

The stock has recorded a 20-day Moving Average of 3.24% and the 50-Day Moving Average is 5.64%.The 200 Day SMA reached 8.44% Globus Medical, Inc. has dropped 4.9% during the last 3-month period . Year-to-Date the stock performance stands at -19.7%.


Globus Medical (GMED) : The most positive equity analysts on Globus Medical (GMED) expects the shares to touch $33, whereas, the least positive believes that the stock will trade at $23 in the short term. The company is covered by 8 Wall Street Brokerage Firms. The average price target for shares are $26.75 with an expected fluctuation of $3.24 from the mean.

For the current week, the company shares have a recommendation consensus of Buy. Globus Medical (NYSE:GMED): stock was range-bound between the intraday low of $22.17 and the intraday high of $22.68 after having opened at $22.67 on Fridays session. The stock finally closed in the red at $22.67, a loss of -1.37%. The stock remained in the red for the whole trading day. The total traded volume was 1,385,151 shares. The stock failed to cross $22.68 in Fridays trading. The stocks closing price on Thursday was $22.34.

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders and spine disorders. Its products consist of two categories: Innovative Fusion and Disruptive Technologies. Innovative Fusion products comprise fusion products to treat various spinal disorders for the entire spine and can be used in various surgical approaches. Disruptive Technologies represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. The Companys portfolio of Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques, as well as treatment alternatives, including motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and biomaterials technologies, as well as interventional pain management solutions.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.